IRB C (Oncology-Focused) was established in September 2012. IRB C is the primary Institutional Review Board designed to review oncology protocols and to address the research growth in Oncology involving human subjects at Augusta University. This includes, but is not limited to:
This applies to all research conducted at Augusta University, GR Medical Center, PPG
sites and Charlie Norwood VA Medical Center or by faculty, staff or students of those
The IRB C also reviews off-campus research conducted by faculty, staff or students of those entities and non-Augusta University researchers using Augusta University facilities.
Submission & Review Schedules
The IRB C meets once a month.
Each convened meeting agenda includes:
Agendas are assigned based on date of expiration (for Continuing Review applications), expertise available on the IRB, number of attending board members, or based on the order in which completed applications are correctly submitted to the IRB. Please note that we are unable to guarantee that your submission will be reviewed at a particular meeting.
How does the IRB Staff determine if a study is ready for FULL board review?
After the IRB Staff completes an administrative analysis of the application, they will verify that all of the following items have been completed before they assign the study for review:
The study will not be assigned to a meeting until these items are complete. Submitting a study does not mean that it will be assigned to a meeting. Please note, it may take up to 5-10 business days for the administrative analysis and assignment to an agenda, based upon the completeness of the submission and number of new protocols submitted.
2016-2017 IRB C Meeting Dates
*Meetings are usually held from 1-5 pm
|IRB Meeting Date||Submission Deadline|